The Chemours Company (NYSE:CC) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET
Company Participants
Brandon Ontjes – Vice President of Investor Relations
Denise M. Dignam – President, CEO & Director
Shane W. Hostetter – Senior VP & CFO
Conference Call Participants
Arun Shankar Viswanathan – RBC Capital Markets, Research Division
Daniel Rizzo – Jefferies LLC, Research Division
Hassan Ijaz Ahmed – Alembic Global Advisors
Jeffrey John Zekauskas – JPMorgan Chase & Co, Research Division
John Ezekiel E. Roberts – Mizuho Securities USA LLC, Research Division
John Patrick McNulty – BMO Capital Markets Equity Research
Joshua David Spector – UBS Investment Bank, Research Division
Justin Timothy Pellegrino – Morgan Stanley, Research Division
Patrick Duffy Fischer – Goldman Sachs Group, Inc., Research Division
Peter Osterland – Truist Securities, Inc., Research Division
Operator
Good morning. My name is Jericho, and I will be your conference operator today. I would like to welcome everyone to The Chemours Company Second Quarter 2025 Results Conference Call. [Operator Instructions] I would like to remind everyone that this conference call is being recorded.
I would now like to hand the conference call over to Brandon Ontjes, Vice President, Head of Strategy and Investor Relations for Chemours. You may begin your conference.
Brandon Ontjes
Good morning, everybody. Welcome to The Chemours Company’s Second Quarter 2025 Earnings Conference Call. I’m joined today by Denise Dignam, Chemours’ President and Chief Executive Officer; and our Senior Vice President and Chief Financial Officer, Shane Hostetter.
Before we start, I would like to remind you that the comments made on this call as well as in the supplemental information provided on our website contain forward-looking statements that involve risks and uncertainties as described in Chemours’ SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations
#Chemours #Company #Earnings #Call #Transcript